share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Paulson Richard A.

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Paulson Richard A.

bluebird bio | 4:持股变动声明-董事 Paulson Richard A.
美股SEC公告 ·  2024/11/08 15:17

Moomoo AI 已提取核心信息

On November 6, 2024, Richard A. Paulson, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction has been completed as per the latest filing. Following this grant, Paulson's direct holdings in the company have increased to a total of 29,563 shares. The grant is part of the company's compensation or incentive strategy, allowing executives and key employees to align their interests with those of the shareholders.
On November 6, 2024, Richard A. Paulson, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction has been completed as per the latest filing. Following this grant, Paulson's direct holdings in the company have increased to a total of 29,563 shares. The grant is part of the company's compensation or incentive strategy, allowing executives and key employees to align their interests with those of the shareholders.
2024年11月6日,理查德·A·保尔森与蓝鸟生物公司[BLUE]相关,获得了24,900股普通股,且不收取任何费用。根据最新申报文件,该交易已完成。在此次授予之后,保尔森在公司的直接持股增至总共29,563股。该授予是公司补偿或激励策略的一部分,允许高管和关键员工将其利益与股东利益保持一致。
2024年11月6日,理查德·A·保尔森与蓝鸟生物公司[BLUE]相关,获得了24,900股普通股,且不收取任何费用。根据最新申报文件,该交易已完成。在此次授予之后,保尔森在公司的直接持股增至总共29,563股。该授予是公司补偿或激励策略的一部分,允许高管和关键员工将其利益与股东利益保持一致。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息